白眉蝮蛇蛇毒神经生长因子的研究Ⅰ.神经生长因子(NGF)的纯化及其生物学活性鉴定

研究白眉蝮蛇蛇毒神经生长因子纯化方法并行生物学活性鉴定。方法从白眉蝮蛇乌苏里亚种蛇毒中,经硫酸胺分段盐析,提取含有神经生长因子的粗制品,再经二乙氨基乙基纤维素离子交换层析和羧甲基纤维素离子交换层析,分离出蛋白质纯品,经十二烷基磺酸钠——聚丙烯酰胺凝胶电泳进行鉴定,结果纯化的纯品为单一区带,分子量为４３ｋｕ。生物学活性鉴定证明分离出的该蛋白质纯品可促进神经细胞突起密集生长。     

白眉蝮蛇蛇毒神经生长因子的研究：Ⅰ.神经生长因子（NGF）的纯化及其生物学？

研究白眉蝮蛇蛇毒神经生长因子纯化方法并行生物学活性鉴定。方法 从白眉蝮蛇乌苏里亚种蛇毒中,经硫酸胺分段盐析,提取含有神经生长因子的粗制品,再经二乙氨基乙基纤维素离子交换层析和羧甲基纤维素离子交换层析,分离出蛋白质纯品,经十二烷基磺酸钠－聚丙烯酰胺凝胶电泳进行鉴定。     

长白蝮蛇类凝血酶基因的克隆及分析

从长白蝮蛇（Agkistrodon halys Ussuriensis)毒腺中抽提总RNA,采用RT－PCR扩增其类凝血酶基因,经全序列测定,类凝血酶基因Ussurin全长为708个核苷酸,即编码236个氨基酸;根据同源性,推测它的活性中心为His^43,Asp^88和Ser^182;二硫键为Cys^7-Cys^141,Cys^28-Cys^44,Cys^76-Cys^234,Cys^120-Cys^188,Cys^152-Cys^167和Cys^178-Cys^203。该蛇毒类凝血酶cDNA序列及推导的氨基酸序列均为首次报道。     

长白山白眉蝮蛇毒类凝血酶Gussurobin基因的克隆、表达与纯化

根据同源性 ,在高度保守的上游信号肽区域设计引物 ,通过RT PCR反应 ,从长白山白眉蝮蛇 (Gloydiusussurensis)毒腺总RNA中克隆得到类凝血酶 gussurobincDNA ,双向测序得到 gussurobin基因的全序列并由此推测出相应的氨基酸序列。与其他已知的类凝血酶不同 ,gussurobin只含有一个可能的糖基化位点 ,即Asn12 4 Ser12 5 Thr12 6。将gussurobin基因克隆到表达载体 pPIC9K中 ,电极转化至毕氏酵母菌株GS115中 ,经G418抗性筛选和营养缺陷型筛选获得重组子。经摇瓶培养 ,获得表达。经过柱层析分离 ,获得SDS PAGE电泳纯的重组gussurobin。     

五步蛇蛇毒类凝血酶N端的部分氨基酸序列

从五步蛇蛇毒中纯化得到的类凝血酶,在SDS-PAGE及IEF均为一条带,且分子质量约38 ku,等电点约为4.0。测定该酶N端15个氨基酸的序列是VIGGVECDINEHRFL,与其他的蛇毒类凝血酶有高度同源性。     

草莓MDHAR及AO基因的克隆及序列分析

从新鲜幼嫩‘丰香’草莓(Fragaria×ananassa cv.Toyonaka)果实中提取分离总RNA,反转录成cDNA,根据已报道的其他植物单脱氢抗坏血酸还原酶(MDHAR)及抗坏血酸氧化酶(AO)基因的保守区分别设计 一对引物,通过PCR扩增均得到目的条带.序列分析发现:mdhar基因片段长372bp,与刺梨同源性最高达96％,该片段编码123个氨基酸,推导的氨基酸序列与苹果属植物同源性为91％,与其他植物该基因编码的氨基酸序列也有较高相似性;a基因片段长842 bp,编码280个氨基酸,该片段与其他多种植物的ao基因均具有较高同源性,与甜瓜和黄瓜ao基因的同源性最高,均为70％,编码的氨基酸序列与其他多种植物均具有70％左右的相似性.     

长白蝮蛇类凝血酶基因的克隆及分析

从长白蝮蛇（Agkistrodon halys Ussurin)毒腺中抽提总RNA,采用RT－PCR扩增其类凝血酶基因,经全序列测定,获得2个类凝血酶基因,ussurin和ussurase,它们全长分别为708和699个核苷酸,即分别编码236和233个氨基酸;根据同源性,推测它们的活性中心分别为His^43,Asp^88和Ser^182与His^40,Asp^85和Ser^179;二硫键分别为Cys^7-Cys^141,Cys^28-Cys^44,Cys^76-Cys^234,Cys^120-Cys^188,Cys^152-Cys^167和Cys^178-Cys^203;与Cys^7-Cys^138,Cys^25-Cys^41,Cys^73-Cys^231,Cys^117-Cys^185,Cys^149-Cys^164和Cys^175-Cys^200。该蛇毒类凝血酶cDNA序列及推导的氨基酸序列为首次报道。     

山羊卵泡刺激素β-亚基cDNA的分子克隆与序列分析

从新屠宰的母山羊脑垂体中提取总RNA,反转录获得cDNA,以皮cDNA为模板用PCR法扩增目的片段,获得长为390bp的山羊卵泡刺激素β－亚基cNDA片段,与预期的目的片段大小一致。将它克隆至pMD-18-T-Verctor中,随机挑选2个阳性重组子进行测序,并将测序结果与绵羊,牛等多种哺乳动物该基因的核苷酸序列及相应氨基酸序列进行比较。结果表明,山羊的卵泡刺激素β－亚基因与绵羊的该基因氨基酸同源性最高,达99．9％,只有1个氨基酸不同,与牛,猪,马,虎,人,大鼠的该基因氨基酸同源性分别为92.5%,91.7%,89.9%,89.1%,86.0%,83.7%。从核苷酸同源性来看,山羊的卵泡刺激素β－亚基因与绵羊该基因的同源性了高,达98％;与牛,猪,马,虎,人,大鼠的核苷酸同源性为95％,90％,90％,88％,86％,84％。结果表明,尽管β－亚基基因有种的特异性,但在哺乳动物中其同源性还是很高的。     

蛇毒类凝血酶的基因工程研究进展

自 1 936年 Klobusitzki和 Konig首次从美洲矛头蝮蛇 ( Bothrops jararaca)毒中获得部分纯化的类凝血酶以来 ,迄今已发现 30多种蛇毒中含有类凝血酶组份 ,并有 2 0多种先后得到分离和纯化。尤其近年来基于有关蛇毒类凝血酶分子结构及酶学性质的研究成果 ,部分蛇毒类凝血酶已经作为治疗药物而广泛应用于临床 ,如国外的 Ancrod和Batroxobin蛇毒抗凝剂 ,国内的五步蛇毒去纤酶、东北白眉蝮蛇抗栓酶 (清栓酶 )、江浙蝮蛇抗栓酶等已广泛用于临床治疗脑血栓形成、脉管炎、冠心病、心肌梗死 ,也有用于治疗癌痛综合症 [1]。但目前有关蛇毒类凝血酶…     

东北白眉蝮蛇毒类凝血酶的分离纯化

我国多年来因技术原因 ,一直使用多组份混合成分的蛇毒制剂 ,临床上虽有一定疗效 ,但存在严重的副作用。作者利用细胞融合技术成功地建立了一株高表达类凝血酶抗体的细胞系 ,该抗体经纯化后 ,可高效亲和白眉蝮蛇类凝血酶。该技术使纯化蛇毒类凝血酶工艺有了很大的飞跃 ,也使蛇毒制品质量达到世界先进水平。方法 :采用天然蛇毒经 DEAE-琼脂糖凝胶层析 ,收集活性组份 ,再经葡聚糖凝胶 G- 75柱层析后 ,收集活性组份 ,最后经类凝血酶亲和柱层析 ,测定 2 80 nm的光吸收度 ,收集蛋白峰 ,测定活性 ,获得了单一组份的类凝血酶 ,即为纯化的类凝血酶…     

Molecular characterization of BjussuSP-I, a new thrombin-like enzyme with procoagulant and kallikrein-like activity isolated from Bothrops jararacussu snake venom

A thrombin-like enzyme, named BjussuSP-I, isolated from Bothrops jararacussu snake venom, is an acidic single-chain glycoprotein with M(r)=61,000, pI approximately 3.8 and 6% sugar. BjussuSP-I shows high proteolytic activity upon synthetic substrates, such as S-2238 and S-2288. It also shows procoagulant and kallikrein-like activity, but is unable to act on platelets and plasmin. These activities are inhibited by specific inhibitors of this class of enzymes. The complete cDNA sequence of BjussuSP-I with 696bp encodes open reading frames of 232 amino acid residues, which conserve the common domains of thrombin-like serine proteases. BjussuSP-I shows a high structural homology with other thrombin-like enzymes from snake venoms where common amino acid residues are identified as those corresponding to the catalytic site and subsites S1, S2 and S3 already reported. In this study, we also demonstrated the importance of N-linked glycans to improve thrombin-like activity of BjussuSP-I toxin.     

cDNA cloning and expression of acutin

Acutin, a thrombin-like enzyme was purified from Agkistrodon acutus venom in three steps by DEAE-Sepharose CL-6B, Superose 12 column on FPLC and Mono-Q column chromatographies. Its first 15 N-terminal amino acid residues sequence was then determined and the acutin cDNA was isolated from venom gland total RNA using RT-PCR. Determination of its nucleotide sequence allowed elucidation of the amino acid sequence of mature peptide for the first time. The mature acutin has 233 amino acids and its amino acid sequence exhibits significant homology with those of thrombin-like enzymes from crotaline snakes venoms. Based on the homology, the catalytic residues and disulfide bridges of acutin were deduced to be as follows: catalytic residues, His41, Asp84 and Ser179; and disulfide bridges, Cys7-Cys139, Cys26-Cys42, Cys74-Cys231, Cys118-Cys185, Cys150-Cys164, Cys175-Cys200. The recombinant acutin has been expressed in E. coli and purified by affinity column. The renatured recombinant acutin is reported for the first time to have the activity of clotting fibrinogen and arginine-esterase.     

小地老虎β-N-乙酰葡萄糖胺糖苷酶基因cDNA序列的克隆及mRNA组织特异性表达

β-N-乙酰葡萄糖胺糖苷酶是昆虫几丁质代谢中一种关键酶,在昆虫的多种生理活动中发挥重要作用。本文以小地老虎Agrotis ipsilon Hufngel预蛹期幼虫为材料提取总RNA,利用RT-PCR和RACE技术,扩增得到其β-N-乙酰葡萄糖胺糖苷酶基因的cDNA序列。该序列含有2701个碱基,包括一个1788个碱基的开放阅读框,编码一个含595个氨基酸的蛋白,分子量约为68.3ku,等电点为5.48。推导得到的氨基酸序列与其他昆虫,尤其是鳞翅目昆虫的β-N-乙酰葡萄糖胺糖苷酶高度同源。基因cDNA序列已经登录GenBank并获得登录号GU985280。该基因在小地老虎取食期和预蛹期的马氏管、中肠、脂肪体、体壁和去中肠虫体中均含有mRNA水平的表达。     

Molecular cloning and sequence analysis of cDNA for batroxobin, a thrombin-like snake venom enzyme

Determination of the nucleotide sequence of a cDNA for batroxobin, a thrombin-like enzyme from Bothrops atrox, moojeni venom, allowed elucidation of the complete amino acid sequence of batroxobin for the first time for a thrombin-like snake venom enzyme. The molecular weight of batroxobin is 25,503 (231 amino acids). The amino acid sequence of batroxobin exhibits significant homology with those of mammalian serine proteases (trypsin, pancreatic kallikrein, and thrombin), indicating that batroxobin is a member of the serine protease family. Based on this homology and enzymatic and chemical studies, the catalytic residues and disulfide bridges of batroxobin were deduced to be as follows: catalytic residues, His41, Asp86, and Ser178; and disulfide bridges, Cys7-Cys139, Cys26-Cys42, Cys74-Cys230, Cys118-Cys184, Cys150-Cys163, and Cys174-Cys199. The amino-terminal amino acid residue of batroxobin, valine, is preceded by 24 amino acids. This may indicate that the amino-terminal hydrophobic peptide (18 amino acids) is a prepeptide and that the hydrophilic peptide (6 amino acids), preceded by the putative prepeptide, is a propeptide.     

Characterization of cerastobin, a thrombin-like enzyme from the venom of Cerastes vipera (Sahara sand viper)

Cerastobin, a thrombin-like enzyme, was isolated from the venom of Cerastes vipera (Sahara sand viper) in homogeneous form. Cerastobin had a molecular weight of 38,000 with 348 amino acid residues. It had an isoelectric point of 7.7 (a pH optimum of 7.9 and a temperature optimum of 45 degrees C). Cerastobin hydrolyzed arginine-containing synthetic substrates such as TAME, BAME, and BAEE, but BAPNA was not hydrolyzed. Cerastobin had thrombin-like activity, producing fibrin from fibrinogen and also hydrolyzing chromogenic substrates for thrombin such as 2AcOH.H-D-CHG-But-Arg-pNA (CBS 34.47) and H-D-Phe-Pip-Arg-pNA (S-2238). It showed kallikrein-like activity and hydrolyzed kallikrein substrates 2AcOH.H-D-Phe-Gly-Arg-pNA (CBS 33.27) and H-D-Pro-Phe-Arg-pNA (S-2302). It produced bradykinin from bradykininogen, as uterus contraction was observed. A serine inhibitor, DFP, exerted a pronounced inhibitory effect, suggesting that cerastobin is a serine-type protease. The sequence of 37 residues from the amino-terminal end was investigated. The amino-terminal amino acid was valine as it is in most other thrombin-like enzymes. The amino acid sequence of cerastobin was similar to that of thrombin in some residues and had some homology with that of kallikrein. However, cerastobin showed a high degree of homology to thrombin-like enzymes isolated from various snake venoms. Factor X was partially degraded by cerastobin. It was also found that antithrombin III was degraded by the enzyme. The alpha and beta chains of fibrin monomer were preferentially hydrolyzed by cerastobin, but the gamma chain was quite resistant.     

BjussuSP-I: a new thrombin-like enzyme isolated from Bothrops jararacussu snake venom

A thrombin-like enzyme named BjussuSP-I, isolated from B. jararacussu snake venom, is an acidic single chain glycoprotein with approximately 6% sugar, Mr=61,000 under reducing conditions and pI approximately 3.8, representing 1.09% of the chromatographic A(280) recovery. BjussuSP-I is a glycosylated serine protease containing both N-linked carbohydrates and sialic acid in its structure. BjussuSP-I showed a high clotting activity upon human plasma, which was inhibited by PMSF, leupeptin, heparin and 1,10-phenantroline. This enzyme showed high stability regarding coagulant activity when analyzed at different temperatures (-70 to 37 degrees C), pHs (4.5 to 8.0), and presence of two divalent metal ions (Ca(2+) and Mg(2+)). It also displayed TAME esterase and proteolytic activities toward natural (fibrinogen and fibrin) and synthetic (BAPNA) substrates, respectively, being also inhibited by PMSF and leupeptin. BjussuSP-I can induce production of polyclonal antibodies able to inhibit its clotting activity, but unable to inhibit its proteolytic activity on fibrinogen. The enzyme also showed crossed immunoreactivity against 11 venom samples of Bothrops, 1 of Crotalus, and 1 of Calloselasma snakes, in addition of LAAO isolated from B. moojeni venom. It displayed neither hemorrhagic, myotoxic, edema-inducing profiles nor proteolytic activity on casein. BjussuSP-I showed an N-terminal sequence (VLGGDECDINEHPFLA FLYS) similar to other thrombin-like enzymes from snake venoms. Based on its biochemical, enzymatic and pharmacological characteristics, BjussuSP-I was identified as a new thrombin-like enzyme isoform from Bothrops jararacussu snake venom.     

Isolation and characterization of the thrombin-like enzyme from Cryptelytrops albolabris (white-lipped tree viper) venom

A thrombin-like enzyme (termed albolabrase) was isolated in purified form from the venom of Cryptelytrops albolabris (white-lipped tree viper) using high performance anion ion exchange and gel filtration chromatography. The molecular mass of albolabrase was 33.7 kDa as determined by SDS-PAGE and 35.8 kDa as determined by Superose gel filtration chromatography. The N-terminal sequence was determined to be VVGGDECNINE which is homologous to many snake venom thrombin-like enzymes. Albolabrase exhibits both arginine ester hydrolase and arginine amidase activities and the enzyme is fastidious towards tripeptide chromogenic anilide substrates. The fibrinogen clotting activity was optimum at 3 mg/mL bovine fibrinogen, and showed distinct species differences in the following decreasing order: bovine fibrinogen > dog fibrinogen ≈ human fibrinogen > goat fibrinogen. The enzyme failed to clot both rabbit and cat fibrinogens. Reversed-phase HPLC analysis on the breakdown products of fibrinogenolytic action of albolabrase indicated that the enzyme belongs to the AB class of snake venom thrombin-like enzyme. In the indirect ELISA, IgG anti-albolabrase reacted extensively with most crotalid venoms, except with Tropidolaemus wagleri and Calloselasma rhodostoma venoms. The double sandwich ELISA, however, showed that anti-albolabrase reacted strongly only with venoms from the Trimeresurus complex, and that the results support the proposed new taxonomy changes concerning the Trimeresurus complex.     

On the modeling of snake venom serine proteinase interactions with benzamidine-based thrombin inhibitors

Pit viper venoms contain a number of serine proteinases that exhibit one or more thrombin-like activities on fibrinogen and platelets, this being the case for the kinin-releasing and fibrinogen-clotting KN-BJ from the venom of Bothrops jararaca. A three-dimensional structural model of the KN-BJ2 serine proteinase was built by homology modeling using the snake venom plasminogen activator TSV-PA as a major template and porcine kallikrein as additional structural support. A set of intrinsic buried waters was included in the model and its behavior under dynamic conditions was molecular dynamics simulated, revealing a most interesting similarity pattern to kallikrein. The benzamidine-based thrombin inhibitors alpha-NAPAP, 3-TAPAP, and 4-TAPAP were docked into the refined model, allowing for a more insightful functional characterization of the enzyme and a better understanding of the reported comparatively low affinity of KN-BJ2 toward those inhibitors.